Hi fattchoi!
Yes - that is indeed the question. Study 305 seems to be a purely IMU/City of Hope generated study. It was not carried out by Amgen, so far as I can see. All the study authors are CoH or IMU people.
So it looks like Saul and Yuman decided to widen the application of OnCARlytics beyond CAR-T combinations. Blincyto is a "Bispecific T cell engager (BiTE) monoclonal antibody."
This goes way beyond my pay grade, but they are very different to a CAR-T. Instead of taking a patient's T cells, altering them, cloning them, and using them as a treatment (CAR-T), the BiTE is administered to the patient and it binds to the patient's existing immune system T-cells, and also to the cancer cells - in effect bringing them together and forcing the T cell to attack the cancer cell. Very clever!
Blincyto targets the CD19 protein found on the Leukaemia cells. OnCARlytic forces solid tumours to express CD19 as well - so I guess it was a logical experiment for them to carry out. Blincyto is available on the market - so they didn't need Amgen's permission.
If I was a senior guy in Amgen, I would certainly be blinking. An effective treatment for Triple Negative Breast Cancer is a huge need, and a huge market, and if this combo gives Blincyto a "robust anti-tumour efficacy" against TNBC, it could/should work against any other solid tumour which can be forced by OnCARlytics to express CD19. That would be........ omg.....
Blink
Lol
Dave
- Forums
- ASX - By Stock
- Media Thread
Hi fattchoi!Yes - that is indeed the question. Study 305 seems...
-
- There are more pages in this discussion • 8,357 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the BĂ©cancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M |
Open | High | Low | Value | Volume |
4.9¢ | 4.9¢ | 4.8¢ | $328.5K | 6.792M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
45 | 5443565 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 2171910 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
36 | 4613688 | 0.048 |
36 | 4066646 | 0.047 |
46 | 3070983 | 0.046 |
60 | 6170008 | 0.045 |
11 | 1951364 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 1200533 | 2 |
0.050 | 4130537 | 15 |
0.051 | 6179811 | 13 |
0.052 | 2579418 | 10 |
0.053 | 1158504 | 8 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |